Groupe pharmaceutique · Suisse
Roche
Un groupe de 34 sociétés, avec 1 000 médicaments dans 11 pays.
Structure du groupe
34 sociétés dans 20 pays
Chargement de votre page…
Chargement de votre page…
Groupe pharmaceutique · Suisse
Un groupe de 34 sociétés, avec 1 000 médicaments dans 11 pays.
34 sociétés dans 20 pays
Un compte gratuit pour les apps Prognia : Ward pour réviser, Osler pour des réponses cliniques avec leurs sources, et le réseau pour retrouver vos collègues.
Les groupes sont constitués par Prognia à partir des noms publiés par les autorités et des liens entre sociétés ; ils ne reflètent pas une structure juridique officielle.
Tous les médicaments de toutes les sociétés du groupe, les actuels d’abord.
1–25 sur 1 000
| Médicament | Substance active | Pays | Statut | Autorisation |
|---|---|---|---|---|
| ACCUTANE10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Isotretinoin | États-Unis | Non commercialisé | 1982 |
| ACTEMRA162 mg / 0.9 ml · Solution | Tocilizumab | Canada | Commercialisé | 2019 |
| Actemra162mg/0.9ml · Injection | Tocilizumab | États-Unis | Commercialisé | 2018 |
| ACTEMRA200 mg / 10 ml · Solution | Tocilizumab | Canada | Commercialisé | 2010 |
| ACTEMRA162 mg / 0.9 ml · Solution | Tocilizumab | Canada | Commercialisé | 2014 |
| ACTEMRA80 mg / 4 ml · Solution | Tocilizumab | Canada | Commercialisé | 2010 |
| ACTEMRA200mg/10ml | 400mg/20ml | 80mg/4ml · Injectable | Tocilizumab | États-Unis | Commercialisé | 2010 |
| ACTEMRA400 mg / 20 ml · Solution | Tocilizumab | Canada | Commercialisé | 2010 |
| ACTEMRA162mg/0.9ml · Injectable | Tocilizumab | États-Unis | Commercialisé | 2013 |
| Actemra 162mg Solution for Injection in Pre-filled Syringe 162mg/0.9ml162 mg/0.9 mL · Injection, solution | Tocilizumab | Singapour | Autorisé | 2015 |
| Actemra Concentrate for Solution for Infusion 20mg/ml20mg/ml · Infusion, solution concentrate | Tocilizumab | Singapour | Autorisé | 2009 |
| Actemra®80mg/4mL · koncentrat za rastvor za infuziju | Tocilizumab | Serbie | Autorisé | 2025 |
| Actemra®200mg/10mL · koncentrat za rastvor za infuziju | Tocilizumab | Serbie | Autorisé | 2025 |
| Actemra®162mg · rastvor za injekciju u napunjenom injekcionom špricu | Tocilizumab | Serbie | Autorisé | 2025 |
| Actemra®400mg/20mL · koncentrat za rastvor za infuziju | Tocilizumab | Serbie | Autorisé | 2025 |
| ACTIVASE100mg/vial | 50mg/vial · Vial | Alteplase | États-Unis | Commercialisé | 1987 |
| ACTIVASE RT-PA100 mg / kit + 100 ml / kit · Liquid, Powder For Solution | Alteplase, Water | Canada | Commercialisé | 1996 |
| ACTIVASE RT-PA50 mg / kit + 50 ml / kit · Liquid, Powder For Solution | Alteplase, Water | Canada | Commercialisé | 1998 |
| AEROBID0.25mg/inh · Aerosol, metered | Flunisolide | États-Unis | Non commercialisé | 1984 |
| ALECENSACapsula rigida | Alectinib | Italie | Autorisé | |
| ALECENSA150mg base · Capsule | Alectinib | États-Unis | Commercialisé | 2015 |
| Alecensa | Alectinib | UE (EMA) | Autorisé | 2017 |
| ALECENSA 150 MG CAPSULAS DURAS161,33 mg · Cápsula dura | Alectinib | Espagne | Commercialisé | 2025 |
| ALECENSA 150 MG CAPSULAS DURAS161,33 mg · Cápsula dura | Alectinib | Espagne | Autorisé | 2026 |
| ALECENSA 150 MG CAPSULAS DURAS161,33 mg · Cápsula dura | Alectinib | Espagne | Commercialisé | 2017 |
Où ses médicaments sont enregistrés ou fabriqués, et combien sont actuels.
| Pays | Médicaments | Actuels | Anciens | Sociétés |
|---|---|---|---|---|
| Canada | 238 | 82 | 156 | SociétésTous les médicaments |
| États-Unis | 145 | 139 | 6 | SociétésTous les médicaments |
| Espagne | 144 | 126 | 18 | SociétésTous les médicaments |
| Arabie saoudite | 132 | 132 | 0 | SociétésTous les médicaments |
| Pays-Bas | 90 | 90 | 0 | SociétésTous les médicaments |
| Singapour | 61 | 61 | 0 | SociétésTous les médicaments |
| Roumanie | 58 | 0 | 58 | SociétésTous les médicaments |
| Serbie | 57 | 51 | 6 | SociétésTous les médicaments |
| Union européenne (EMA) | 40 | 30 | 10 | SociétésTous les médicaments |
| Italie | 33 | 33 | 0 | SociétésTous les médicaments |
| Croatie | 2 | 2 | 0 | SociétésTous les médicaments |
Également dans les registres : Brésil, France, Royaume-Uni
Les groupes ATC auxquels appartiennent la plupart de ses médicaments, les plus importants d’abord.
Les substances actives présentes dans la plupart de ses médicaments.
Comment les registres l’écrivent, normalisé : sans forme juridique, accents ni majuscules.
Compilé par Prognia à partir des registres publics de médicaments et d’entreprises ci-dessous. Aucun logo n’est utilisé.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence : EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence : AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence : Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence : Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence : Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence : Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence : Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence : AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence : AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence : BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; Crown copyright MHRA factual register
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence : CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence : Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
AIFA; Gazzetta Ufficiale della Repubblica Italiana. Exact act IDs, publication dates, locators, URLs and retrieval dates. Normalized by Prognia; no official endorsement.
Licence : Official administrative act text exclusion, Italian Law633/1941 Article5
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence : Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence : Italian Open Data Licence
State Enterprise Centre of Registers / Valstybės įmonė Registrų centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Licence : Creative Commons Attribution
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence : Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licence : Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence : Creative Commons Attribution 4.0 International (CC BY 4.0)
Oficiul Național al Registrului Comerțului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence : Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence : Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence : Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licence : Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence : Singapore Open Data Licence
Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licence : Creative Commons Attribution
Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licence : CC0
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence : FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Signaler une erreur ou demander un retraitLes corrections de la société elle-même sont les bienvenues.
Roche : veillez à l’exactitude de vos médicaments sur Prognia, voyez comment les professionnels les utilisent et répondez à leurs questions. Un appel de 20 minutes, en anglais.
Réserver un appelDes groupes pharmaceutiques connus, chacun avec toutes ses sociétés.
Classés selon leur nombre de médicaments.